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Introduction
A perioperative hemodynamic goal-directed therapy
(GDT) has been advocated in patients undergoing high
risk-surgery in order to reduce postoperative complica-
tions. Nevertheless, the benefits of GDT in surgical
patients are controversial and may lead to an overuse of
fluids, inotropic agents and blood transfusion.
Objectives
The aim of this randomized, controlled, single-center
trial was to assess the effect of GDT after abdominal
oncology surgery on the incidence of major postoperative
complications. We also evaluated the requirements of
fluid, inotropic agents, blood transfusion and the inten-
sive care unit (ICU) and hospital length of stay between
groups.
Methods
We randomly assigned patients admitted to the ICU after
major abdominal oncology surgery to receive either GDT
protocol or usual care. The GDT protocol involved
hemodynamic optimization aimed at a target of a cardiac
index >2.5 L/minute/m2 (by minimally invasive cardiac
output monitoring) and a mean arterial pressure of
70 mmHg through a three-step approach: fluid therapy
of 250 ml albumin 4% in lactated Ringer´s solution, dobu-
tamine infusion up to a dose of 20 µg/kg/minute, and red
blood cell transfusion to reach a hemoglobin level above
8g/dL. The primary outcome was a 30-day composite
endpoint of acute kidney injury, major cardiovascular
complications, adult respiratory distress syndrome, septic
shock, reoperation and mortality.
Results
Of the 125 enrolled patients, 62 were assigned to GDT-
group and 63 to the usual-care group. There was no dif-
ference between groups regarding the amount of fluids
received during 8 hours (1345 mL [1042-1771] vs. 1100
mL [780-1388], p = 0.151) of intervention and during
24 hours (2021 mL [1527-2844] vs. 2010 mL [1747-
2410], p = 0.372). Patients in the GDT-group were more
likely to receive dobutamine (37[66.1%] vs. 12 [23.1%],
p < 0.0001). At 30 days after randomization, the compo-
site endpoint occurred in 25.8% in the GDT group and
in 22.2% in the usual-care group (p = 0.639). There was
no significant difference in blood transfusion require-
ments, in-hospital mortality, duration of organ support, or
length of hospital stay.
Conclusions
In surgical critically ill patients admitted to the ICU after
major abdominal oncology surgery, a GDT protocol did
not reduce the incidence of major postoperative compli-
cations at 30 days. Also, the GDT protocol was associated
with an overuse of inotropic agents. (ClinicalTrials.gov
number, NCT 01946269.)
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